The N and C-terminal deleted variant of the dengue virus NS1 protein is a potential candidate for dengue vaccine development

Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504–507 (2013).Article 
ADS 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Kyle, J. L. & Harris, E. Global spread and persistence of dengue. Annu. Rev. Microbiol. 62, 71–92 (2008).Article 
CAS 
PubMed 

Google Scholar 
World Health Organization. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control (World Health Organization, 1997).
Google Scholar 
Nasar, S., Rashid, N. & Iftikhar, S. Dengue proteins with their role in pathogenesis, and strategies for developing an effective anti-dengue treatment: A review. J. Med. Virol. 92, 941–955 (2020).Article 
CAS 
PubMed 

Google Scholar 
Beatty, P. R. et al. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci. Transl. Med. 7, 304ra141 (2015).Article 
PubMed 

Google Scholar 
Flamand, M. et al. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J. Virol. 73, 6104–6110 (1999).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Somnuke, P., Hauhart, R. E., Atkinson, J. P., Diamond, M. S. & Avirutnan, P. N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement. Virology 413, 253–264 (2011).Article 
CAS 
PubMed 

Google Scholar 
Thiemmeca, S. et al. Secreted NS1 protects dengue virus from mannose-binding lectin-mediated neutralization. J. Immunol. 197, 4053–4065 (2016).Article 
CAS 
PubMed 

Google Scholar 
Kassim, F. M., Izati, M. N., TgRogayah, T., Apandi, Y. M. & Saat, Z. Use of dengue NS1 antigen for early diagnosis of dengue virus infection. Southeast Asian J. Trop. Med. Public Health 42, 562–569 (2011).CAS 
PubMed 

Google Scholar 
Datta, S. & Wattal, C. Dengue NS1 antigen detection: A useful tool in early diagnosis of dengue virus infection. Indian J. Med. Microbiol. 28, 107 (2010).Article 
CAS 
PubMed 

Google Scholar 
Puerta-Guardo, H., Glasner, D. R. & Harris, E. Dengue virus NS1 disrupts the endothelial glycocalyx, leading to hyperpermeability. PLoS Pathog. 12, e1005738 (2016).Article 
PubMed 
PubMed Central 

Google Scholar 
Puerta-Guardo, H. et al. Flavivirus NS1 triggers tissue-specific vascular endothelial dysfunction reflecting disease tropism. Cell Rep. 26, 1598-1613.e8 (2019).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Modhiran, N. et al. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci. Transl. Med. 7, 304ra142 (2015).Article 
PubMed 

Google Scholar 
Puerta-Guardo, H. et al. The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability. J. Virol. 87, 7486–7501 (2013).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Conde, J. N. et al. Inhibition of the membrane attack complex by dengue virus NS1 through interaction with vitronectin and terminal complement proteins. J. Virol. 90, 9570–9581 (2016).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Chu, Y.-T. et al. Antibodies against nonstructural protein 1 protect mice from dengue virus-induced mast cell activation. Lab. Investig. 97, 602–614 (2017).Article 
CAS 
PubMed 

Google Scholar 
Henchal, E., Henchal, L. & Schlesinger, J. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J. Gen. Virol. 69, 2101–2107 (1988).Article 
PubMed 

Google Scholar 
Lee, P. X. et al. Relative contribution of nonstructural protein 1 in dengue pathogenesis. J. Exp. Med. 217, e20191548 (2020).Article 
PubMed 
PubMed Central 

Google Scholar 
Falconar, A. The dengue virus nonstructural-1 protein (NS1) generatesantibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to humanendothelial cells: Potential implications in haemorrhagic fever pathogenesis. Arch. Virol. 142, 897–916 (1997).Article 
CAS 
PubMed 

Google Scholar 
Chung, K. M., Thompson, B. S., Fremont, D. H. & Diamond, M. S. Antibody recognition of cell surface-associated NS1 triggers Fc-γ receptor-mediated phagocytosis and clearance of West Nile virus-infected cells. J. Virol. 81, 9551–9555 (2007).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Biering, S. B. et al. Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction. Science 371, 194–200 (2021).Article 
ADS 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Modhiran, N. et al. A broadly protective antibody that targets the flavivirus NS1 protein. Science 371, 190–194 (2021).Article 
ADS 
CAS 
PubMed 

Google Scholar 
Alcalá, A. C. et al. The dengue virus non-structural protein 1 (NS1) is secreted efficiently from infected mosquito cells. Virology 488, 278–287 (2016).Article 
PubMed 

Google Scholar 
Alcon, S. et al. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J. Clin. Microbiol. 40, 376–381 (2002).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Suckow, M. A., Schroeder, V. & Douglas, F. A. The Laboratory Rabbit (CRC Press, 2010).Book 

Google Scholar 
Qi, H. et al. Rapid production of virus protein microarray using protein microarray fabrication through gene synthesis (PAGES). Mol. Cell. Proteom. 16, 288–299 (2017).Article 
CAS 

Google Scholar 
Kinney, R. M. et al. Construction of infectious cDNA clones for dengue 2 virus: Strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230, 300–308 (1997).Article 
CAS 
PubMed 

Google Scholar 
Sabetian, S., Nezafat, N., Dorosti, H., Zarei, M. & Ghasemi, Y. Exploring dengue proteome to design an effective epitope-based vaccine against dengue virus. J. Biomol. Struct. Dyn. 37, 2546–2563 (2019).Article 
CAS 
PubMed 

Google Scholar 
Peyrefitte, C. N. et al. Genetic characterization of newly reintroduced dengue virus type 3 in Martinique (French West Indies). J. Clin. Microbiol. 41, 5195–5198 (2003).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Hoque, H. et al. Implementation of in silico methods to predict common epitopes for vaccine development against Chikungunya and Mayaro viruses. Heliyon 7, e06396 (2021).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Whitehead, S. S. et al. A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3′ untranslated region is highly attenuated and immunogenic in monkeys. J. Virol. 77, 1653–1657 (2003).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Abdi, S. A. H., Ali, A., Sayed, S. F., Ali, A. & Alam, P. Multi-epitope-based vaccine candidate for monkeypox: An in silico approach. Vaccines 10, 1564 (2022).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Enayatkhani, M. et al. Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: An in silico study. J. Biomol. Struct. Dyn. 39, 2857–2872 (2021).Article 
CAS 
PubMed 

Google Scholar 
Vaure, C. & Liu, Y. A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front. Immunol. 2014(5), 316 (2014).
Google Scholar 
Modhiran, N. et al. Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6. Immunol. Cell Biol. 95, 491–495 (2017).Article 
CAS 
PubMed 

Google Scholar 
Schneidman-Duhovny, D., Inbar, Y., Nussinov, R. & Wolfson, H. J. PatchDock and SymmDock: Servers for rigid and symmetric docking. Nucleic Acids Res. 33, W363–W367 (2005).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Ahsan, F., Arif, A., Mahmood, N., Rashid, N. & Akhtar, M. Characterization and bioassay of post-translationally modified interferon α-2b expressed in Escherichia coli. J. Biotechnol. 184, 11–16 (2014).Article 
CAS 
PubMed 

Google Scholar 
Canadian Council on Animal Care. Guidelines on Antibody Production (Canadian Council on Animal Care, 2002).
Google Scholar 
Chuang, Y.-C., Lin, J., Lin, Y.-S., Wang, S. & Yeh, T.-M. Dengue virus nonstructural protein 1-induced antibodies cross-react with human plasminogen and enhance its activation. J. Immunol. 196, 1218–1226 (2016).Article 
CAS 
PubMed 

Google Scholar 
Lin, Y.-S. et al. Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Exp. Biol. Med. 236, 515–523 (2011).Article 
CAS 

Google Scholar 
Roy, P., Roy, S. & Sengupta, N. Disulfide reduction allosterically destabilizes the β-ladder subdomain assembly within the NS1 dimer of ZIKV. Biophys. J. 119, 1525–1537 (2020).Article 
ADS 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Wallis, T. P., Huang, C.-Y., Nimkar, S. B., Young, P. R. & Gorman, J. J. Determination of the disulfide bond arrangement of dengue virus NS1 protein. J. Biol. Chem. 279, 20729–20741 (2004).Article 
CAS 
PubMed 

Google Scholar 
Pryor, M. J. & Wright, P. J. The effects of site-directed mutagenesis on the dimerization and secretion of the NS1 protein specified by dengue virus. Virology 194, 769–780 (1993).Article 
CAS 
PubMed 

Google Scholar 
Shu, B. et al. CryoEM structures of the multimeric secreted NS1, a major factor for dengue hemorrhagic fever. Nat. Commun. 13, 6756 (2022).Article 
ADS 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Quirino-Teixeira, A. C. et al. Inflammatory signaling in dengue-infected platelets requires translation and secretion of nonstructural protein 1. Blood Adv. 4, 2018–2031 (2020).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Nielsen, B. L., Willis, V. C. & Lin, C. Y. Western blot analysis to illustrate relative control levels of the lac and ara promoters in Escherichia coli. Biochem. Mol. Biol. Educ. 35, 133–137 (2007).Article 
CAS 
PubMed 

Google Scholar 
Hassan, N. Studies on Genetically Engineered Precursors of Human Insulin and their Derivatives (University of the Punjab, 2019).
Google Scholar 
Akey, D. L., Brown, W. C., Jose, J., Kuhn, R. J. & Smith, J. L. Structure-guided insights on the role of NS1 in flavivirus infection. Bioessays 37, 489–494 (2015).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Scaturro, P., Cortese, M., Chatel-Chaix, L., Fischl, W. & Bartenschlager, R. Dengue virus non-structural protein 1 modulates infectious particle production via interaction with the structural proteins. PLoS Pathog. 11, e1005277 (2015).Article 
PubMed 
PubMed Central 

Google Scholar 
Chao, C.-H. et al. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage. PLoS Pathog. 15, e1007625 (2019).Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 
Wu, S.-F. et al. Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice. Vaccine 21, 3919–3929 (2003).Article 
CAS 
PubMed 

Google Scholar